Tranexamic acid for heavy menstrual bleeding in patients on anticoagulation for thromboembolic events

Verifisert
National Institute for Health and Care Research
Type
Tilskudd
Frist
Utløpt 24. september 2025
Program
Health Technology Assessment

Om ordningen

- Funding programme: Health Technology Assessment - Opening date: 2025-03-27 - Closing date: 2025-09-24

Our Health Technology Assessment (HTA) Programme is looking to fund research into tranexamic acid for heavy menstrual bleeding in patients on anticoagulation for thromboembolic events.

Full eligibility, award value and application detail are published on the opportunity's own page: https://www.nihr.ac.uk/funding/tranexamic-acid-heavy-menstrual-bleeding-patients-anticoagulation-thromboembolic-events/2025250

Ofte stilte spørsmål

Hvem står bak Tranexamic acid for heavy menstrual bleeding in patients on anticoagulation for thromboembolic events?
Tranexamic acid for heavy menstrual bleeding in patients on anticoagulation for thromboembolic events er en tilskudd fra National Institute for Health and Care Research.
Hvordan søker man på Tranexamic acid for heavy menstrual bleeding in patients on anticoagulation for thromboembolic events?
Du søker hos National Institute for Health and Care Research via lenken på denne siden. Virkely hjelper deg å skrive selve søknaden — fra organisasjonsnummer til ferdig tekst.

Skal du søke Tranexamic acid for heavy menstrual bleeding in patients on anticoagulation for thromboembolic events?

Virkely hjelper deg å skrive søknaden — fra organisasjonsnummer til ferdig tekst. Ingen innlogging.

Start søknaden

Flere ordninger fra National Institute for Health and Care Research

Relaterte kategorier